Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
Barnes A, Ooi SJ, Lynch KD, Parthasarathy N, Bishara M, Gounder M, Grafton R, Leach P, Bampton P, Sechi A, Ng W, Connor S, van Langenberg D, Mountifield R, Andrews JM. Barnes A, et al. Among authors: sechi a. Dig Dis Sci. 2023 Mar;68(3):889-896. doi: 10.1007/s10620-022-07556-y. Epub 2022 Jun 10. Dig Dis Sci. 2023. PMID: 35687221 Free PMC article.
Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease.
Krishnaprasad K, Walsh A, Begun J, Bell S, Carter D, Grafton R, Sechi A, Sewell K, McMahon A, Connor S, Radford-Smith G, Andrews JM; Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC) and Crohn’s Colitis Cure (CCC). Krishnaprasad K, et al. Among authors: sechi a. Scand J Gastroenterol. 2020 Dec;55(12):1419-1426. doi: 10.1080/00365521.2020.1839960. Epub 2020 Nov 8. Scand J Gastroenterol. 2020. PMID: 33161791
Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?
Mohsen W, Williams AJ, Wark G, Sechi A, Koo JH, Xuan W, Bassan M, Ng W, Connor S. Mohsen W, et al. Among authors: sechi a. World J Gastroenterol. 2021 Mar 21;27(11):1090-1100. doi: 10.3748/wjg.v27.i11.1090. World J Gastroenterol. 2021. PMID: 33776375 Free PMC article. Clinical Trial.
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.
Doecke JD, Hartnell F, Bampton P, Bell S, Mahy G, Grover Z, Lewindon P, Jones LV, Sewell K, Krishnaprasad K, Prosser R, Marr D, Fischer J, R Thomas G, Tehan JV, Ding NS, Cooke SE, Moss K, Sechi A, De Cruz P, Grafton R, Connor SJ, Lawrance IC, Gearry RB, Andrews JM, Radford-Smith GL; Australian and New Zealand Inflammatory Bowel Disease Consortium. Doecke JD, et al. Among authors: sechi a. Aliment Pharmacol Ther. 2017 Feb;45(4):542-552. doi: 10.1111/apt.13880. Epub 2016 Dec 19. Aliment Pharmacol Ther. 2017. PMID: 27995633
297 results